-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Targets and Technologies for HbF Induction

Program: Friday Scientific Workshops
Session: Improving Fetal Hemoglobin Expression by NHEJ/MMEJ or Base Editing
Hematology Disease Topics & Pathways:
Friday, December 6, 2019, 1:40 PM-2:00 PM
W314, Level 3 (Orange County Convention Center)

Mitchell J. Weiss, MD, PhD

St. Jude Children's Research Hospital, Memphis, TN

Disclosures: Weiss: GlaxoSmithKline: Consultancy; Rubius INC: Consultancy; Beam Therapeutics: Consultancy; Esperion: Consultancy; Cellarity INC: Consultancy.

<< Previous Presentation | Next Presentation